RIGI and neoplasm: These viruses selectively replicate in tumour cells, releasing tumour-associated antigens and triggering innate immune pathways, including TLRs and RIG-I/MDA5, thereby creating an inflamed TME conducive to subsequent immune checkpoint blockade (22) (Table 1).